MedTrace Logo

The Evaluation of TCI378 and TCI507 Probiotics on Weight-lowering Efficacy in Adults

NCT04492605 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 96

Last updated 2026-02-03

No results posted yet for this study

Summary

To assess the evaluation of TCI378 and TCI507 probiotics on weight-lowering efficacy in adults

Conditions

Interventions

DIETARY_SUPPLEMENT

Placebo

consume 1 capsule per day for 2 months

DIETARY_SUPPLEMENT

TCI378 Probiotics

consume 1 capsule per day for 2 months

DIETARY_SUPPLEMENT

TCI507 Probiotics

consume 1 capsule per day for 2 months

Sponsors & Collaborators

  • TCI Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • LIOU JYH-MING · National Taiwan University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-03-09
Primary Completion
2025-10-16
Completion
2026-05-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04492605 on ClinicalTrials.gov